PRECISION BIOSCIENCES ($DTIL) posted quarterly earnings results on Wednesday, March 26th. The company reported earnings of -$3.20 per share, missing estimates of -$2.00 by $1.20. The company also reported revenue of $640,000, missing estimates of $4,360,500 by $-3,720,500.
You can see Quiver Quantitative's $DTIL stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
PRECISION BIOSCIENCES Insider Trading Activity
PRECISION BIOSCIENCES insiders have traded $DTIL stock on the open market 13 times in the past 6 months. Of those trades, 5 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $DTIL stock by insiders over the last 6 months:
- MICHAEL AMOROSO (President and CEO) has made 0 purchases and 3 sales selling 40,814 shares for an estimated $202,061.
- J. JEFFERSON SMITH (Chief Research Officer) has made 0 purchases and 2 sales selling 10,441 shares for an estimated $50,030.
- DARIO SCIMECA (General Counsel and Secretary) has made 0 purchases and 3 sales selling 9,788 shares for an estimated $48,916.
- JOHN ALEXANDER KELLY (Chief Financial Officer) has made 2 purchases buying 5,113 shares for an estimated $30,316 and 0 sales.
- KEVIN BUEHLER purchased 4,320 shares for an estimated $21,081
- GENO J GERMANO purchased 3,605 shares for an estimated $16,186
- MELINDA BROWN purchased 3,016 shares for an estimated $13,722
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
PRECISION BIOSCIENCES Hedge Fund Activity
We have seen 30 institutional investors add shares of PRECISION BIOSCIENCES stock to their portfolio, and 21 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- LYNX1 CAPITAL MANAGEMENT LP added 766,051 shares (+inf%) to their portfolio in Q4 2024, for an estimated $2,918,654
- JANUS HENDERSON GROUP PLC removed 702,069 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $2,674,882
- PERCEPTIVE ADVISORS LLC removed 426,293 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $1,624,176
- GOLDMAN SACHS GROUP INC added 285,862 shares (+1753.1%) to their portfolio in Q4 2024, for an estimated $1,089,134
- AQUILO CAPITAL MANAGEMENT, LLC added 154,573 shares (+40.5%) to their portfolio in Q4 2024, for an estimated $588,923
- ACADIAN ASSET MANAGEMENT LLC added 98,440 shares (+65.5%) to their portfolio in Q4 2024, for an estimated $375,056
- ALYESKA INVESTMENT GROUP, L.P. removed 76,382 shares (-43.3%) from their portfolio in Q4 2024, for an estimated $291,015
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
PRECISION BIOSCIENCES Analyst Ratings
Wall Street analysts have issued reports on $DTIL in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BMO Capital issued a "Outperform" rating on 01/10/2025
To track analyst ratings and price targets for PRECISION BIOSCIENCES, check out Quiver Quantitative's $DTIL forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
